Treffer 1 - 5 von 5 für Suche 'Punzi, Connie F.', Suchdauer: 0,38s Treffer weiter einschränken
  1. 1
    Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study

    Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study von Punzi, Henry A, Punzi, Connie F

    Veröffentlicht in Current hypertension reports

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    P-242: An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension

    P-242: An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients w... von Punzi, Henry A., Punzi, Connie F.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    P-248: A 13-week, double-blind, placebo-controlled, parallel, multicenter study of eprosartan mesylate given in titrated doses of 600mg or 1200 mg once daily in patients with isolated systolic hypertension

    P-248: A 13-week, double-blind, placebo-controlled, parallel, multicenter study of eprosartan mesylate given in titrated doses of 600mg or 1200 mg once daily in patients with isola... von Punzi, Henry A., Punzi, Connie F.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension

    An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with ess... von Punzi, Henry A., Punzi, Connie F.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    A 13-week, double-blind, placebo-controlled, parallel, multicenter study of eprosartan mesylate given in titrated doses of 600mg or 1200 mg once daily in patients with isolated systolic hypertension

    A 13-week, double-blind, placebo-controlled, parallel, multicenter study of eprosartan mesylate given in titrated doses of 600mg or 1200 mg once daily in patients with isolated sys... von Punzi, Henry A., Punzi, Connie F.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: